Wang Ruifang, Yu Yongguo, Ye Jun, Han Lianshu, Qiu Wenjuan, Zhang Huiwen, Liang Lili, Gong Zhuwen, Wang Lili, Gu Xuefan
Department of Pediatric Endocrinology and Genetic Metabolism, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai Institute for Pediatric Research, Shanghai 200092, China.
Department of Pediatric Endocrinology and Genetic Metabolism, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai Institute for Pediatric Research, Shanghai 200092, China.
Steroids. 2016 Apr;108:47-55. doi: 10.1016/j.steroids.2016.01.007. Epub 2016 Jan 21.
Steroid 21-hydroxylase deficiency (21-OHD) caused by the CYP21A2 gene mutations accounts for more than 90% of congenital adrenal hyperplasia (CAH) cases. In this study, molecular defects of 230 patients with 21-OHD were investigated. Point mutations of CYP21A2 gene were analyzed by Sanger sequencing, and large gene deletions were detected by multiplex ligation-dependent probe amplification (MLPA). Nine micro-conversions and 18 spontaneous mutations accounted for 74.6% of alleles, while large gene deletions and large gene conversions accounted for 25.4% of alleles. The most frequent micro-conversion was c.292-13A/C>G (I2G) (35%), followed by p.I173N (14.3%), p.R357W (5.9%) and p.Q319* (4.6%). Nine novel mutations were identified in these patients, which were predicted to hamper the 21-hydroxylase protein function in varying degrees. Genotype and phenotype correlated well in 89.6% of our patients, but disparity in phenotypic appearance also appeared in a small portion of the patients. 16.1% of the patients carried homozygous genotypes while 83.9% of patients carried compound heterozygous mutations. We concluded that the frequency of CYP21A2 mutations in our study was slightly different from those reported for other ethnic groups. Micro-conversions were the main category of the mutation spectrum, while large deletions and large gene conversions could also cause 21-OHD. A large portion of different types of the compound heterozygous genotypes may partially contribute to the discordance in genotype-phenotype comparison. This study expanded the CYP21A2 mutation spectrum of Chinese patients and could be helpful in prenatal diagnosis and genetic counseling for 21-OHD patients.
由CYP21A2基因突变引起的类固醇21-羟化酶缺乏症(21-OHD)占先天性肾上腺皮质增生症(CAH)病例的90%以上。在本研究中,对230例21-OHD患者的分子缺陷进行了调查。通过桑格测序分析CYP21A2基因的点突变,通过多重连接依赖探针扩增(MLPA)检测大片段基因缺失。9个微转化和18个自发突变占等位基因的74.6%,而大片段基因缺失和大片段基因转化占等位基因的25.4%。最常见的微转化是c.292-13A/C>G(I2G)(35%),其次是p.I173N(14.3%)、p.R357W(5.9%)和p.Q319*(4.6%)。在这些患者中鉴定出9个新突变,预计这些突变会不同程度地妨碍21-羟化酶蛋白功能。89.6%的患者基因型与表型相关性良好,但一小部分患者也出现了表型差异。16.1%的患者携带纯合基因型,83.9%的患者携带复合杂合突变。我们得出结论,本研究中CYP21A2突变的频率与其他种族报道的频率略有不同。微转化是突变谱的主要类型,而大片段缺失和大片段基因转化也可导致21-OHD。大部分不同类型的复合杂合基因型可能部分导致基因型-表型比较中的不一致。本研究扩展了中国患者的CYP21A2突变谱,有助于21-OHD患者的产前诊断和遗传咨询。